Request Deal Involvement
Novo Holdings, SR One and Catalys Pacific co-led the $205m Series A financing in Crystalys Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
bidder
LONGWOOD FUND
bidder
PERCEPTIVE XONTOGENY VENTURE FUND
bidder
SR ONE CAPITAL MANAGEMENT
bidder
KB INVESTMENTS
bidder
NOVO HOLDINGS A/S
bidder
CATALYS PACIFIC
target
CRYSTALYS THERAPEUTICS
bidder
LIGHTSTONE VENTURES
bidder
AN VENTURES
bidder
ABRDN INC
bidder
PONTIFAX VENTURE CAPITAL
bidder
ALEXANDRIA VENTURE INVESTMENTS
bidder
PREBYS VENTURES FUND
bidder
WEDBUSH CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite